Future studies should determine if there are common mechanisms of P450 downregulation between enzymes such as CYP2B1 described in this study with CYP2C11 and CYP3A2, which have been consistently shown to be downregulated in similar models of CKD. This evidence concerns the gene CYP2B6 and chronic kidney disease.